While GAS5 upregulation demonstrates clear therapeutic potential in cancer, its effects in cardiovascular and inflammatory diseases rely heavily on the target cell type and context of the disease, allowing it to have either detrimental or protective functions. Here, GAS5 is linked to cancer.